Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function

Keyphrases

• Renal Function 100%
• Clinical Response 100%
• Refractory Ascites 100%
• Hormonal Response 100%
• Transjugular Intrahepatic Portosystemic Shunt 100%
• Response Function 100%
• Ascites 23%
• Diuretics 15%
• Liver Failure 15%
• Clinical Efficacy 7%
• Liver Transplantation 7%
• Effective Therapy 7%
• Non-responders 7%
• Hepatic Function 7%
• Glomerular Filtration Rate 7%
• Adverse Effects 7%
• Cirrhosis 7%
• Renal Disease 7%
• Patient Selection 7%
• Serum Creatinine 7%
• Plasma Renin Activity 7%
• Mean Dose 7%
• Clinical Improvement 7%
• Urinary Sodium Excretion 7%
• Diuretic Therapy 7%
• Derangement 7%
• Plasma Aldosterone Concentration 7%
• Hormonal Parameters 7%

Medicine and Dentistry

• Kidney Function 100%
• Ascites 100%
• Transjugular Intrahepatic Portosystemic Shunt 100%
• Diuretic Agent 15%
• Liver Failure 15%
• Urinary System 7%
• Nephropathy 7%
• Liver Transplantation 7%
• Adverse Event 7%
• Glomerular Filtration Rate 7%
• Creatinine 7%
• Liver Cirrhosis 7%
• Liver Function 7%
• Diuretic Therapy 7%
• Patient Selection 7%
• Sodium Excretion 7%
• Renin 7%
• Aldosterone 7%

Biochemistry, Genetics and Molecular Biology

• Kidney Function 100%
• Plasma Renin Activity 33%
• Glomerulus Filtration 33%
• Creatinine Blood Level 33%
• Liver Function 33%
• Aldosterone Blood Level 33%
• Sodium Urine Level 33%